Invention Grant
- Patent Title: Macrocyclic hepatitis C serine protease inhibitors
-
Application No.: US14170199Application Date: 2014-01-31
-
Publication No.: US09309279B2Publication Date: 2016-04-12
- Inventor: Yiyin Ku , Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , Dale J. Kempf , David J. Grampovnik , Ying Sun , Dong Liu , Yonghua Gai , Yat Sun Or , Seble H. Wagaw , Kenneth Engstrom , Tim Grieme , Ahmad Sheikh , Jianzhang Mei
- Applicant: AbbVie, Inc. , Enanta Pharmaceuticals, Inc.
- Applicant Address: US IL Abbott Park US MA Boston
- Assignee: AbbVie Inc.,Enanta Pharmaceuticals, Inc.
- Current Assignee: AbbVie Inc.,Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US IL Abbott Park US MA Boston
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon
- Main IPC: C07K1/113
- IPC: C07K1/113 ; C07D487/04
Abstract:
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Public/Granted literature
- US20140148573A1 MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS Public/Granted day:2014-05-29
Information query
